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Background and Aims. There are limited data on the diﬀerences in diagnostic yield between 25-gauge and 22-gauge EUS-FNA
needles. This prospective study compared the diﬀerence in diagnostic yield between a 22-gauge and a 25-gauge needle when
performing EUS-FNA. Methods. Forty-three patients with intraluminal or extraluminal mass lesions and/or lymphadenopathy
were enrolled prospectively. EUS-FNA was performed for each mass lesion using both 25- and 22-gauge needles. The diﬀerences
in accuracy rate, scoring of needle visibility, ease of puncture and quantity of obtained specimen were evaluated. Results. The
overall accuracy of 22- and 25-gauge needle was similar at 81% and 76% respectively (N.S). Likewise the visibility scores of both
needles were also similar. Overall the quantity of specimen obtained higher with the 22-gauge needle (score: 1.64 vs. P < .001).
However the 25-gauge needle was significantly superior to the 22-gauge needle in terms of ease of puncture (score: 1.9 vs. 1.29,
P < .001) and in the quantity of specimen in the context of pancreatic mass EUS-FNA (score: 1.8 vs. 1.58, P < .05). Conclusion.
The 22-gauge and 25-gauge needles have similar overall diagnostic yield. The 25-gauge needle appeared superior in the subset of
patients with hard lesions and pancreatic masses.
Copyright © 2009 Hiroo Imazu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Endoscopic ultrasound-guided fine needle aspiration (EUS-
FNA) has become well established as a technique for sam-
pling lesions within the gastrointestinal tract and adjacent
organ including pancreatic tumors, abdominal lymph nodes,
adrenal tumors, mediastinal masses, and gastrointestinal
submucosal tumors. EUS-FNA provides cytological or his-
tological diagnosis for such lesions and has high diagnostic
accuracy, sensitivity, and specificity of 80–90%, 90%, and
100%, respectively [1–4].
The diagnostic accuracy of EUS-FNA is influenced by
several factors, such as anatomical location and stiﬀness of
the target lesion, the experience of the endoscopist, and the
angle of the tip of echoendoscope [5–9]. To overcome these
limitations and obtain adequate tissue sampling, a variety of
EUS-FNA needle devices have been developed, and 19-, 22-,
and 25-gauge configurations are available. The 22-gauge and
19-gauge needles are commonly used for EUS-FNA and have
demonstrated high diagnostic accuracy rates. There are lim-
ited comparative studies on the clinical impact of diﬀerent
needle sizes [8–10]. It remains unclear whether a specific nee-
dle size will be more suitable for a particular type of lesion.
The aim of this nonrandomized prospective cohort study
was to compare the 22-gauge and 25-gauge needles in terms
of diﬀerences in accuracy rate, needle visibility, ease of
puncture, and quantity of the specimen obtained.
2. Patients and Methods
2.1. Patients. The study included prospectively recruited
patients with unknown intra- or extraluminal mass lesions
who were referred for EUS-FNA sampling between January
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2005 and March 2008 at the Department of Endoscopy, The
Jikei University School of Medicine, Tokyo, Japan. Patients
with suspected diagnosis of lymphoma or autoimmune
pancreatitis in which abundant samples were required for
definitive diagnosis were excluded from this study, and EUS-
guided Trucut biopsy was instead performed for these lesions
in our institution. The study was approved by the institution
ethics committee and all patients gave written informed
consent. This was a nonrandomized cohort study.
2.2. Method of Tissue Sampling with EUS-FNA. EUS was per-
formed using the curvilinear echoendoscope (GF-UC2000P
or GU-UCT240-AL5; Olympus Medical Systems, Tokyo,
Japan) under conscious sedation using intravenous midazo-
lam and pethidine. All EUS-FNA procedures were digitally
videotaped to allow subsequent blinded evaluation of the
needle visibility and the ease of puncture. After the lesion was
carefully inspected and vessel interposition along the punc-
ture route excluded by colour Doppler ultrasound, EUS-
FNA was performed twice using the 22-gauge needle and 25-
gauge needle (Echotip; Wilson-Cook, Winston-Salem, NC,
USA) by a single experienced endosonographer (H.I). The
order of needles used for EUS-FNA for all patients in our
study is 22G needle followed by 25G. During each puncture,
the needle traversed the lesion to and fro 10 times with
negative suction applied using a 10mL syringe. The aspirated
specimenwas then placed on glass slides and fixed in absolute
ethanol solution for cytological Papanicolaou staining in all
cases except for patients with submucosal lesions that were
suspected to be gastrointestinal submucosal tumour (GIST).
For cases of suspected GIST, the aspirated material was
placed into formalin solution for histological examination
since histology with immunohistochemistry was necessary
to establish c-kit (CD-117), CD-34, actin, desmin, and S-
100 positivity. The specimens obtained from the first and
second punctures were labeled according to the aspiration
sequence and sent to experienced cytopathologists who were
blinded to type of the needles used. The adequacy of the
specimen obtained was judged by the presence of macro-
scopic material without the presence of a cytopathologist.
After the second aspiration, if further aspiration was needed
to ensure adequacy of specimens, the 22-gauge needle was
used and EUS-FNA was repeated until adequate specimen
was obtained. The results of the first and second aspirations
were compared.
2.3. Evaluation of EUS-FNA Puncture and
Specimen Adequacy (Table 1).
(i) Needle Visibility and Ease of Puncture
The digitally recorded EUS-FNA procedures were
reviewed by another experienced endosonographer (Y.U)
who was blinded to the type of needle used. The char-
acteristics of visibility of the needle and ease of puncture
were documented for the first and second punctures with
the two diﬀerent needles. These characteristics were scored
qualitatively as poor (scored 1), good (scored 2), and
excellent(scored 3).
(ii) Adequacy of EUS-FNA Specimens
The characteristics of quantity of obtained specimens
were reported by cytopathologists who were blinded to
the type of needle used. The characteristics were scored
qualitatively as poor (scored 1), good (scored 2), and
excellent (scored 3).
The final diagnosis was based on the results of EUS-FNA
and surgery. The accuracy and each score were evaluated and
compared between the 22-gauge and 25-gauge needles.
3. Statistics
For statistical analysis, the McNemar test was used for pair-
wise comparison of accuracy of EUS-FNA using 22-gauge
needle and 25-gauge needle, and Wilcoxon signed rank test
was used for pair-wise comparison of each score. For all test,
a P-value less than .05 was regarded as statistically significant
(using Stata version 10 software, StataCorp, Texas, USA).
4. Result
A total of 43 patients were recruited. The final diagnoses were
gastric GIST in 12 patients, gastric leiomyoma in 7, gastric
aberrant pancreas in 1, intra-abdominal schwannoma in 3,
pancreatic cancer in 6, chronic pancreatitis in 6, malignant
lymphadenopathy in 3, benign lymphadenopathy in 3, lung
cancer in 1, and other in 1. Final diagnoses were obtained
by surgery in the all patients with GIST and three with pan-
creatic cancer. In the remaining patients, the final diagnoses
were based on the results of EUS-FNA, including additional
EUS-FNA. The mean diameter of mass lesions in all patients
was 25.7mm in the long axis. The mean diameters of
submucosal tumor and pancreatic lesions were 25.7mm and
22.4mm in their long axis, respectively (Table 2).
Adequate material for cytological or histological
evaluation was obtained in 35 lesions using 22-gauge
needles, and 33 with 25-gauge needles. As a result, the
overall diagnostic accuracy of the 22-gauge needle and the
25-gauge needle was 81.4% (35/43) and 76.7% (33/43),
respectively, (N.S). In 43 patients, the mean score of visibility
of the 22- and 25-gauge needles was 1.74 and 1.76 (N.S).
However, the mean score of ease of puncture using the
25-gauge needle was significantly higher than that of the
22-gauge needle (1.9 versus 1.29, P < .001). On the other
hand, overall the score of quantity of specimen using the
25-gauge needle was significantly lower than the 22-gauge
needle (1.5 versus 1.64, P < .001) (Table 3).
In twenty cases of gastric submucosal tumor, GISTs were
diagnosed in 12, leiomyoma in 7, and aberrant pancreas
in 1. The specimens were obtained using 22- and 25-gauge
needles and evaluated by histological examination with
immunohistochemistry to establish c-kit (CD-117), CD-34,
actin, desmin, and S-100 positivity. Adequate materials for
immunohistochemical evaluation were obtained in 16 out of
20 gastric submucosal tumors with 22-gauge needles and in
12 with 25-gauge needles. As a result, diagnostic accuracy for
submucosal tumor with 22-gauge needle was higher than 25-
gauge needle (80% (16/20) versus 60% (12/20)), although
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Table 1: Scoring of visibility of needle, ease of puncture, and quantity of specimen obtained.
Visibility of needle
0: poor Needle tip is absolutely invisible.
1: good
The needle tip is visible,
although invisible intermittently
during the procedure.
2: excellent The needle tip is visible
throughout the procedure.
Ease of puncture
0: poor Impossible to puncture.
1: good
The needle bends during the
procedure, or the target lesion is
pushed away from the transducer
of the echoendoscope at the time
of puncture.
2: excellent
The puncture is done eﬀortlessly
and the needle never bends
during procedure.
Quantity of the specimen obtained
0: poor No specimen
1: good
Although a small specimen is
obtained, definitive diagnosis is
diﬃcult.
2: excellent Adequate for definitive diagnosis.












the diﬀerence was not statistically significant. Themean score
of quantity of obtained specimen using the 22-gauge needle
for submucosal tumor was significantly higher than 25-gauge
needle (1.7 versus 1.3, P < .001). All punctures using the 22-
and 25-gauge needles were successfully performed in all cases
of submucosal tumor. However, regarding ease of puncture,
the mean score of the 25-gauge needle was significantly
higher than 22-gauge needle (1.95 versus 1.3, P < .001).
The reviewers noted that when 22-gauge needle was used
for submucosal tumor, the targeted lesion and gastric wall
were more likely to move together with the needle, although
it did not easily bent during the procedure. There was no
significant diﬀerence for the score of visibility of needle
between 22- and 25-gauge needles (Table 4).
Six pancreatic cancers and 6 cases of chronic pancreatitis
were diagnosed from 12 patients with pancreatic mass
lesions. The location of pancreatic mass lesions was head of
pancreas in 8, body in 3, and tail in 1. Adequate material
for cytological evaluation was obtained in 9 cases with 22-
gauge needle and 11 with 25-gauge needles. The diagnostic
accuracy for pancreatic mass with 25-gauge needle was
relatively high as compared with 22-gauge needle (91.5%
(11/12) versus 75% (9/12)), although the diﬀerence was not
statistically significant. Although the 22-gauge needle could
not obtain material in one case of pancreatic cancer and one
case of chronic pancreatitis, the 25-gauge needle could obtain
adequatematerial for cytological diagnosis in these two cases.
A representative case was shown in Figure 1. In addition, the
25-gauge needle could acquire adequate material in a case of
chronic pancreatitis; whereas 22-gauge needle could not pro-
vide definitive diagnosis because of inadequate small materi-
als. The opposite result was noted in another case of chronic
pancreatitis. Finally, 22-gauge needle could obtain no mate-
rial in 2 (16.7%) cases of pancreatic lesions and obtain
inadequate materials for definitive diagnosis in 1 (8.3%). On
the other hand, 25-gauge needle could obtain material in all
cases of pancreatic lesions, and it could not obtain adequate
materials for definitive diagnosis in only 1 case (8.3%).
Therefore, the mean score of quantity of obtained specimens
using 25-gauge needle for pancreatic mass lesions was
significantly higher than 22-gauge needle (1.58 versus 1.83,
P < .05). In addition, regarding ease of puncture, the mean
score of 25-gauge needle was significantly higher than the 22-
gauge needle (1.83 versus 1.17, P < .001). The reviewer noted
that when 25-gauge needle was used for pancreatic mass
lesion, the needle tended to penetrate the lesion more per-
pendicularly without bending, and the lesion was not more
likely to be pushed away from transducer of echoendoscope.
On the other hand, 22-gauge needle tended to bend during
the procedure. EUS-FNA using 22-gauge was not successful
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Table 3: Comparison of EUS-FNA with the 22-gauge and 25-gauge needles.
22G 25G P
Diagnostic accuracy 81.4% (35/43) 76.7% (33/43) N.S
Visibility of the needle 1.74 ± 0.44 1.76 ± 0.43 N.S
Ease of puncture 1.29 ± 0.55 1.9 ± 0.29 P < .001
Quantity of the specimens obtained 1.64 ± 0.68 1.5 ± 0.73 P < .001
Table 4: Comparison of EUS-FNA of submucosal tumours with the 22-gauge and 25-gauge needles.
22G 25G P
Accuracy 80% (16/20) 60% (12/20) N.S
Visibility of the needle 1.7 ± 0.45 1.65 ± 0.48 N.S
Ease of puncture 1.3 ± 0.46 1.95 ± 0.22 P < .001
Quantity of the specimens obtained 1.7 ± 0.64 1.3 ± 0.84 P < .001
Table 5: Comparison of EUS-FNA of pancreatic masses with the 22-gauge and 25-gauge needles.
22G 25G P
Accuracy 75% (9/12) 91.7% (11/12) N.S
Visibility of the needle 1.83 ± 0.37 1.83 ± 0.37 N.S
Ease of puncture 1.17 ± 0.55 1.83 ± 0.37 P < .001
Quantity of the specimens obtained 1.58 ± 0.76 1.83 ± 0.37 P < .05
in one case of chronic pancreatitis because of the firmness
and rigidity of the lesion, although successful puncture
using the 25-gauge needle was achieved in all 12 cases with
pancreatic mass. There was no significant diﬀerence for the
score of visibility of needle between 22- and 25-gauge needles
(Table 5).
There were no procedure-related complications irrespec-
tive of the type of needles used.
5. Discussion
EUS-FNA has high and well-established diagnostic accuracy
with a very high safety [11–14]. However, its diagnostic
accuracy might be limited by several factors including
anatomical location and consistency of lesions.
When a hard tumor is punctured, bending of the needle
may occur resulting in the needle tip not being visualized
on the ultrasonic image [15]. In addition, the needle tip
will also not be visualized if the tip of the echoendoscope
cannot be securely fixed in the duodenum and is pushed away
from the targeted lesion during EUS-FNA. These limitations
could lead to inadequate sampling with EUS-FNA [9, 15].
The diagnostic yield of EUS-FNA for pancreatic head masses
is lower than that of mediastinal lesions [16–19]. This may
be explained by the fact the for pancreas head masses, EUS-
FNA is performed from the duodenum, where the tip of the
echoendoscope may be bent and hence less stable. Gastric
submucosal masses including GIST are also diﬃcult to
puncture because the gastric wall tends to move considerably
together with the needle. Furthermore abundant tissue is
necessary in the diagnosis of submucosal tumours because
immunohistochemical staining is required to diﬀerentiate
GIST from leiomyoma and neurogenic tumor. This diﬃculty
in EUS-FNA and the need to acquire abundant tissue could
also result in a lower diagnostic accuracy rate in submucosal
tumors [15, 20].
In order to overcome these limitations, a variety of
EUS-FNA needle devices have been developed and are now
available in 19-, 22-, and 25-gauge sizes. EUS-FNA using
the 22-gauge needle has been the most extensively studied
and shown to have a high diagnostic accuracy rate of 95 to
100% for pancreatic cancer [18, 19] and 82 to 91% for GIST,
respectively [20, 21]. However, there are only few reports on
the clinical impact of EUS-FNA using the 25-gauge needle
[22]. Furthermore, there are very limited comparative studies
to clarify which needle size is more suitable for a particular
type of lesion [8–10, 22]. Therefore, we embarked on a
comparative study on the use of 25- and 22-gauge needles
for EUS-FNA.
Our results showed that the overall diagnostic accuracy
of the 22-gauge needle was similar to the 25-gauge needle
(81.4% versus 76.7%, P > .05). However the score of
quantity of specimen obtained using the 22-gauge needle was
significantly higher than the 25-gauge needle (1.64 versus
1.5). These results suggest that a larger diameter of needle
has the advantage of acquiringmore tissue, as compared with
a smaller diameter needle. Indeed, this advantage became
more evident in patients with submucosal tumor, where
abundant material was necessary for diagnosis by histology
with immunohistochemistry. However, the score of ease of
puncture by the 25-gauge needle was significantly higher
than 22-gauge needle (1.9 versus 1.29). This statistically
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(a) (b)
Figure 1: EUS-FNA images for pancreatic head cancer using (a) 22-gauge and (b) 25-gauge needles. The tip of the 22-gauge needle was bent
within the lesion during the puncture, and no material was obtained. The arrow indicates the bent tip of the 22-gauge needle. The 25-gauge
needle tip remained straight during the EUS-FNA procedure (arrow), and pancreatic adenocarcinoma was diagnosed with EUS-FNA using
the 25-gauge needle.
significant diﬀerence was also seen in patients with sub-
mucosal tumor (1.3 versus 1.95). Nonetheless, diagnostic
yield of EUS-FNA using 22-gauge needle was superior to 25-
gauge needle in patients with submucosal tumor. The ease of
puncture using the 25-gauge needle might not influence the
accuracy and the quantity of obtained specimen in patients
with submucosal tumors.
Diverging results were seen in patients with pancreatic
masses. The diagnostic accuracy of the 25-gauge needle for
a pancreatic mass lesion was significantly higher than that
of the 22-gauge needle (91.7% versus 75%). The score of
quantity of obtained specimen obtained using the 25-gauge
needle was also significantly higher than the 22-gauge
needle. The score of ease of puncture using the 25-gauge
needle was significantly higher than 22-gauge needle. In
patients with pancreatic mass, a larger diameter of needle
might not necessarily lead to better results. The ease of
puncture using the 25-gauge needle in pancreatic masses,
which tend to be hard in consistency, may account for the
increased diagnostic accuracy and quantity of obtained
specimen in pancreatic lesions.
There were clearly diﬀerent outcomes in the diagnostic
yield between the diﬀerent needle types for submucosal
tumors and pancreatic lesions. Possible reasons for the
diﬀerent outcomes might be related to the characteristics of
diﬃculty of puncture for each particular lesion. The needle
and gastric wall were likely tomove together during puncture
when 22-gauge needle was used. As a result, several puncture
attempts were needed before the needle could traverse
deep into the lesion. However, 22-gauge needle could move
without bending once it had successfully penetrated into
the lesion. Because all punctures using 22- and 25-gauge
needles were performed successfully for submucosal tumors
in this study, the ease of puncture using the 25-gauge needle
might not influence the diagnostic accuracy and quantity of
the specimen obtained. Pancreatic tumors are known to be
extremely firm, which may not only resist needle penetration
but also prevent adequate tissue sampling. The bent shaft
of the echoendoscope when it rested on the duodenal wall
during EUS-FNA for pancreatic head mass could prevent
smooth movement of the needle within the accessory
channel [5, 9, 23]. Itoi et al. have shown that the diagnostic
accuracy of the 22-gauge needle for pancreatic mass in the
head and uncinate process was higher than that of the 19-
gauge needle [8]. Recently, Sakamoto et al. also showed that
the 25-gauge needle was superior to the 22-gauge needle
for overall diagnostic accuracy in the context of EUS-FNA
of pancreatic head and uncinate lesions [22]. In our 8 out
of 12 pancreatic head lesions, 25-gauge needles tended to
penetrate and move more perpendicular into pancreatic
masses without bending as compared with 22-gauge needles.
In addition, 22-gauge needle could not penetrate into the
pancreas in patients with chronic pancreatitis because of its
hardness. Thus, smaller diameter needles, which are sharper,
might have an advantage over larger ones in EUS-FNA for
pancreatic mass. Therefore, the ease of puncture using 25-
gauge needle might influence the diagnostic accuracy and
quantity of obtained specimen from pancreatic lesions.
In conclusion, no significant diﬀerences were detected in
the diagnostic accuracy and visibility between 22- and 25-
gauge needles. However, ease of puncture using 25-gauge
needle was significantly superior to 22-gauge needle. The
quantity of the specimen obtained was better with the 25-
gauge needle for pancreatic lesions; whereas the 22-gauge
needle was better for submucosal tumors. The decision to
use either the 22-gauge or 25-gauge needle should be based
on the characteristics of the targeted lesions. However, our
study has several limitations, including small number of
patients, lesions in various locations, and diﬀerent types of
pathology. Therefore, further studies are warranted to clarify
the feasibility of diﬀerent types of EUS-FNA needles for
diﬀerent lesions.
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